Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
20.5M
-
Shares change
-
+621K
-
Total reported value, excl. options
-
$153M
-
Value change
-
+$3.92M
-
Put/Call ratio
-
1.02
-
Number of buys
-
23
-
Number of sells
-
-20
-
Price
-
$7.47
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q4 2021
63 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q4 2021.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.5M shares
of 98M outstanding shares and own 20.95% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (5.22M shares), FMR LLC (4.17M shares), VR Adviser, LLC (1.57M shares), Tikvah Management LLC (1.23M shares), TANG CAPITAL MANAGEMENT LLC (1.11M shares), VANGUARD GROUP INC (1.11M shares), Deep Track Capital, LP (1.1M shares), Alyeska Investment Group, L.P. (675K shares), BAKER BROS. ADVISORS LP (625K shares), and Stonepine Capital Management, LLC (526K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.